{
  "$schema": "https://themachinepress.com/schemas/story-v1.schema.json",
  "schema_version": "1.0.0",
  "document_type": "machine_press_story",
  "story": {
    "story_id": "mp-2026-07-17-027",
    "source_story_id": "tmp-story-glp1-neovascular-amd-no-link",
    "edition_id": "mp-2026-07-17-morning-0008",
    "edition_url": "https://themachinepress.com/edition/2026-07-17",
    "position": 16,
    "story_type": "dispatch",
    "section": "research",
    "editorial_classification": "editorial",
    "headline": "A 200,000-Patient Study Finds No GLP-1 Link to One Eye Disease",
    "slug": "a-200-000-patient-study-finds-no-glp-1-link-to-one-eye-disease",
    "dek": "First-time users showed no statistically significant change in neovascular macular-degeneration risk.",
    "summary": "First-time users showed no statistically significant change in neovascular macular-degeneration risk.",
    "body_text": "Johns Hopkins compared records from 12 databases for adults starting GLP-1 drugs or comparators. More than 200,000 first-time semaglutide users plus other cohorts showed no significant increase or decrease in new neovascular AMD. The retrospective study concerns one eye condition and should not guide medication changes without a clinician.",
    "why_it_matters": "First-time users showed no statistically significant change in neovascular macular-degeneration risk.",
    "limitations": [
      "The retrospective study concerns one eye condition and should not guide medication changes without a clinician."
    ],
    "importance": 8,
    "canonical_url": "https://themachinepress.com/story/mp-2026-07-17-027/a-200-000-patient-study-finds-no-glp-1-link-to-one-eye-disease",
    "json_url": "https://themachinepress.com/story/mp-2026-07-17-027.json",
    "first_published_at": "2026-07-17T09:00:00.000-04:00",
    "modified_at": "2026-07-17T14:34:04.943-04:00",
    "content_status": "new",
    "is_carryover": false,
    "carryover_reason": null,
    "key_claims": [
      {
        "claim_id": "claim-mp-2026-07-17-027-001",
        "text": "First-time users showed no statistically significant change in neovascular macular-degeneration risk.",
        "source_ids": [
          "source-2026-07-17-016"
        ],
        "qualification": "The retrospective study concerns one eye condition and should not guide medication changes without a clinician."
      }
    ],
    "source_ids": [
      "source-2026-07-17-016"
    ],
    "tags": [
      "GLP-1",
      "semaglutide",
      "macular degeneration"
    ],
    "image_url": null,
    "corrections": []
  },
  "sources": [
    {
      "source_id": "source-2026-07-17-016",
      "title": "Johns Hopkins via Newswise: GLP-1 and eye disease",
      "publisher": "Johns Hopkins via Newswise",
      "url": "https://www.newswise.com/articles/study-finds-no-statistical-link-between-use-of-semaglutide-and-other-glp-1-drugs-and-risk-of-degenerative-eye-disease-in-adults-with-type-2-diabetes",
      "canonical_url": "https://www.newswise.com/articles/study-finds-no-statistical-link-between-use-of-semaglutide-and-other-glp-1-drugs-and-risk-of-degenerative-eye-disease-in-adults-with-type-2-diabetes",
      "source_type": "secondary_reporting",
      "is_primary_source": false,
      "published_at": "2026-07-17T10:00:00.000-04:00",
      "accessed_at": "2026-07-17T11:30:57.481-04:00",
      "supports_claim_ids": [
        "claim-mp-2026-07-17-027-001"
      ]
    }
  ],
  "corrections": [],
  "publisher": {
    "name": "The Machine Press",
    "url": "https://themachinepress.com",
    "description": "A daily newspaper for the age of artificial intelligence."
  },
  "cite_this_report": {
    "title": "A 200,000-Patient Study Finds No GLP-1 Link to One Eye Disease",
    "publisher": "The Machine Press",
    "published_at": "2026-07-17T09:00:00.000-04:00",
    "canonical_url": "https://themachinepress.com/story/mp-2026-07-17-027/a-200-000-patient-study-finds-no-glp-1-link-to-one-eye-disease"
  }
}